Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Deven Chauhan

ResearcherPublications, citations & collaboration network

Deven Chauhan is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 24 works, 356 citations, an h-index of 9 and an i10-index of 9.

24
Works
356
Citations
9
h-index
9
i10-index

How has Deven Chauhan's publication output changed over time?

ScholarIQpublication output · 2007–2024

Output grew100% over the shown period — from 1 works in 2007 to 2 in 2024.

1
1
1
1
1
2
1
1
2
200720082013201420172021202220232024

What are the most-cited papers on Deven Chauhan?

ScholarIQmost cited works
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Vincent Meininger, Angela Genge, Leonard H van den Berg, Wim Robberecht, Albert C. Ludolph, Adriano Chiò, Seung Hyun Kim, P. Nigel Leigh, Matthew C. Kiernan, Jeremy M. Shefner, Claude Desnuelle, Karen Morrison, Susanne Petri, Diane Boswell, Jane Temple, Rajat Mohindra, Matt Davies, Jonathan Bullman, Patricia Rees, Arseniy Lavrov, Susanne Abdulla, Cathy Alsop, Francesca Barbieri, Stewart Bates, James D. Berry, Stéphan A. Botez, Gaëlle Bruneteau, Andrea Calvo, Rodrigo Refoios Camejo, William Camu, Deven Chauhan, Veronique Danel-Brunaud, Jerzy Daniluk, Annelot Dekker, A. Destée, Matthew Devine, Stephen DeWall, Johannes Dorst, Giuseppe Fuda, Harutoshi Fujimura, Andreas Funke, Torsten Grehl, Julian Großkreutz, Usha Gungabissoon, Robert D. Henderson, Peggy P. Ho, William Huynh, Saiju Jacob, Raúl Juntas‐Morales, Byung‐Jo Kim, Xenia Kobeleva, Sonja Koerner, Stephen J. Kolb, Katja Kollewe, Lawrence Korngut, Géraldine Lautrette, Amy Lee, Anthony Lynch, Rami Massie, Geneviève Matte, Daniel L. Menezes, Stefano Milleri, Linda Nichols, Kazutoshi Nishiyama, Mieko Ogino, C. J. Parkinson, Pierre-François Pradat, Tino Prell, Jeffrey Price, Eleanor Ramsey, Thomas Ringer, Kristiana Salmon, Christen Shoesmith, Marie‐Hélène Soriani, Marloes Stam, Erik Steinberg, R.S. Stubbs, H. R. Sullivan, Philip Van Damme, Michael A. van Es, Anne E Visser, Mary Lou Watson, Andrea Sylvia Winkler, Lorne Zinman, Margie C. Zoing
S70053155. 201785 CitationsOPEN ACCESS
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
Murray B. Urowitz, Cynthia Aranow, Yumi Asukai, Damon Bass, Ian N Bruce, Deven Chauhan, Maria Dall’Era, Richard Furie, Norma Lynn Fox, Jennifer Gilbride, Anne E. Hammer, Ellen M. Ginzler, Tania Gonzalez‐Rivera, Roger A. Levy, Joan T. Merrill, Holly Quasny, David A. Roth, William Stohl, Ronald van Vollenhoven, Daniel J. Wallace, Michelle Petri
Arthritis Care & Research. 202243 CitationsOPEN ACCESS
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis
Sarah Acaster, R Perard, Deven Chauhan, Andrew Lloyd
BMC Health Services Research. 201334 CitationsOPEN ACCESS
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
Ioannis Parodis, Julius Lindblom, Roger A. Levy, Margherita Zen, Nurşen Çetrez, Alvaro Gómez, Shereen Oon, Christine Henning, Munther A. Khamashta, Holly Quasny, Deven Chauhan, Anca Askanase, Ronald van Vollenhoven, Mandana Nikpour
S4210233594. 202434 CitationsOPEN ACCESS

Related on ScholarIQ

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Paper
Factors affecting the uptake of new medicines in secondary care a literature review
Paper
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
Paper
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis
Paper
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
Paper
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
Paper
470M+ articles · free account